129 related articles for article (PubMed ID: 16052228)
1. Stable inhibition of human thymidylate synthase expression following retroviral introduction of an siRNA gene.
Yang Z; Cloud A; Hughes D; Johnson LF
Cancer Gene Ther; 2006 Jan; 13(1):107-14. PubMed ID: 16052228
[TBL] [Abstract][Full Text] [Related]
2. Posttranscriptional regulation of thymidylate synthase gene expression.
Johnson LF
J Cell Biochem; 1994 Apr; 54(4):387-92. PubMed ID: 8014187
[TBL] [Abstract][Full Text] [Related]
3. Combining small interfering RNAs targeting thymidylate synthase and thymidine kinase 1 or 2 sensitizes human tumor cells to 5-fluorodeoxyuridine and pemetrexed.
Di Cresce C; Figueredo R; Ferguson PJ; Vincent MD; Koropatnick J
J Pharmacol Exp Ther; 2011 Sep; 338(3):952-63. PubMed ID: 21673071
[TBL] [Abstract][Full Text] [Related]
4. A "combination oligonucleotide" antisense strategy to downregulate thymidylate synthase and decrease tumor cell growth and drug resistance.
Berg RW; Ferguson PJ; Vincent MD; Koropatnick DJ
Cancer Gene Ther; 2003 Apr; 10(4):278-86. PubMed ID: 12679800
[TBL] [Abstract][Full Text] [Related]
5. Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer.
Xi Y; Nakajima G; Schmitz JC; Chu E; Ju J
BMC Genomics; 2006 Apr; 7():68. PubMed ID: 16584549
[TBL] [Abstract][Full Text] [Related]
6. Pre-mRNA processing enhancer (PPE) element increases the expression of an intronless thymidylate synthase gene but does not affect intron-dependent S phase regulation.
Lee TX; Johnson LF
J Cell Biochem; 1998 May; 69(2):104-16. PubMed ID: 9548559
[TBL] [Abstract][Full Text] [Related]
7. Small interfering RNA-mediated suppression of dUTPase sensitizes cancer cell lines to thymidylate synthase inhibition.
Koehler SE; Ladner RD
Mol Pharmacol; 2004 Sep; 66(3):620-6. PubMed ID: 15322254
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of thymidylate synthase activity by antisense oligodeoxynucleotide and possible role in thymineless treatment.
Lin SB; Ts'o PO; Sun SK; Choo KB; Yang FY; Lim YP; Tsai HL; Au LC
Mol Pharmacol; 2001 Sep; 60(3):474-9. PubMed ID: 11502877
[TBL] [Abstract][Full Text] [Related]
9. Combination silencer RNA (siRNA) targeting Bcl-2 antagonizes siRNA against thymidylate synthase in human tumor cell lines.
Pandyra AA; Berg R; Vincent M; Koropatnick J
J Pharmacol Exp Ther; 2007 Jul; 322(1):123-32. PubMed ID: 17452420
[TBL] [Abstract][Full Text] [Related]
10. Desensitization and sensitization of cells to fluoropyrimidines with different antisenses directed against thymidylate synthase messenger RNA.
Ju J; Kane SE; Lenz HJ; Danenberg KD; Chu E; Danenberg PV
Clin Cancer Res; 1998 Sep; 4(9):2229-36. PubMed ID: 9748143
[TBL] [Abstract][Full Text] [Related]
11. Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase.
Nivens MC; Felder T; Galloway AH; Pena MM; Pouliot JJ; Spencer HT
Cancer Chemother Pharmacol; 2004 Feb; 53(2):107-15. PubMed ID: 14605862
[TBL] [Abstract][Full Text] [Related]
12. Antisense nucleic acids targeted to the thymidylate synthase (TS) mRNA translation start site stimulate TS gene transcription.
DeMoor JM; Vincent MD; Collins OM; Koropatnick J
Exp Cell Res; 1998 Aug; 243(1):11-21. PubMed ID: 9716444
[TBL] [Abstract][Full Text] [Related]
13. Introduction of an initiator element in the mouse thymidylate synthase promoter alters S phase regulation but has no effect on promoter bidirectionality.
Kapadia F; Johnson LF
J Cell Biochem; 2006 Feb; 97(3):599-608. PubMed ID: 16215980
[TBL] [Abstract][Full Text] [Related]
14. Regulation of thymidylate synthase enzyme synthesis in 5-fluorodeoxyuridine-resistant mouse fibroblasts during the transition from the resting to growing state.
Jenh CH; Rao LG; Johnson LF
J Cell Physiol; 1985 Jan; 122(1):149-54. PubMed ID: 3155521
[TBL] [Abstract][Full Text] [Related]
15. Long-term suppression of telomerase expression in HeLa cell clones, transfected with an expression vector carrying siRNA targeting hTERT mRNA.
Kurvinen K; Syrjänen S; Johansson B
Int J Oncol; 2006 Jul; 29(1):279-88. PubMed ID: 16773210
[TBL] [Abstract][Full Text] [Related]
16. Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells.
Berger SH; Jenh CH; Johnson LF; Berger FG
Mol Pharmacol; 1985 Nov; 28(5):461-7. PubMed ID: 2932632
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Ki-67 by small interfering RNA leads to inhibition of proliferation and induction of apoptosis in human renal carcinoma cells.
Zheng JN; Ma TX; Cao JY; Sun XQ; Chen JC; Li W; Wen RM; Sun YF; Pei DS
Life Sci; 2006 Jan; 78(7):724-9. PubMed ID: 16111722
[TBL] [Abstract][Full Text] [Related]
18. Sequence analysis and functional study of thymidylate synthase from zebrafish, Danio rerio.
Du C; Niu R; Chu E; Zhang P; Lin X
J Biochem; 2006 May; 139(5):913-20. PubMed ID: 16751599
[TBL] [Abstract][Full Text] [Related]
19. In vitro sensitivity to platinum-derived drugs is associated with expression of thymidylate synthase and dihydropyrimidine dehydrogenase in human lung cancer.
Takizawa M; Kawakami K; Obata T; Matsumoto I; Ohta Y; Oda M; Sasaki T; Watanabe G
Oncol Rep; 2006 Jun; 15(6):1533-9. PubMed ID: 16685392
[TBL] [Abstract][Full Text] [Related]
20. The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition.
Webley SD; Welsh SJ; Jackman AL; Aherne GW
Br J Cancer; 2001 Aug; 85(3):446-52. PubMed ID: 11487279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
